Efficacy of tofacitinib in synovitis, acne, pustulosis, hyperostosis and osteitis syndrome: a pilot study with clinical and MRI evaluation. (Record no. 30898261)

MARC details
000 -LEADER
fixed length control field 01411 a2200397 4500
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20250518100620.0
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 202009s 0 0 eng d
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER
International Standard Serial Number 1468-2060
024 7# - OTHER STANDARD IDENTIFIER
Standard number or code 10.1136/annrheumdis-2020-217250
Source of number or code doi
040 ## - CATALOGING SOURCE
Original cataloging agency NLM
Language of cataloging eng
Transcribing agency NLM
100 1# - MAIN ENTRY--PERSONAL NAME
Personal name Li, Yueting
264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE
Date of production, publication, distribution, manufacture, or copyright notice 20200930
245 00 - TITLE STATEMENT
Title Efficacy of tofacitinib in synovitis, acne, pustulosis, hyperostosis and osteitis syndrome: a pilot study with clinical and MRI evaluation.
Medium [electronic resource]
260 ## - PUBLICATION, DISTRIBUTION, ETC.
Name of publisher, distributor, etc. Annals of the rheumatic diseases
Date of publication, distribution, etc. 09 2020
300 ## - PHYSICAL DESCRIPTION
Extent 1255-1257 p.
Other physical details digital
500 ## - GENERAL NOTE
General note Publication Type: Letter; Research Support, Non-U.S. Gov't
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Acquired Hyperostosis Syndrome
General subdivision drug therapy
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Adult
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Female
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Humans
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Pilot Projects
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Piperidines
General subdivision therapeutic use
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Protein Kinase Inhibitors
General subdivision therapeutic use
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Pyrimidines
General subdivision therapeutic use
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Pyrroles
General subdivision therapeutic use
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Treatment Outcome
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Huo, Jianwei
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Cao, Yihan
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Yu, Meiyan
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Zhang, Yanan
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Li, Zhaohui
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Li, Chen
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Zhang, Wen
773 0# - HOST ITEM ENTRY
Title Annals of the rheumatic diseases
Related parts vol. 79
-- no. 9
-- p. 1255-1257
856 40 - ELECTRONIC LOCATION AND ACCESS
Uniform Resource Identifier <a href="https://doi.org/10.1136/annrheumdis-2020-217250">https://doi.org/10.1136/annrheumdis-2020-217250</a>
Public note Available from publisher's website

No items available.